Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by GoPats1


TSTIF

RE:RE:RE:RE:RE:Trump targets pharma

Lastly, on behalf of those who rely on this board to stay current on the...

January 12, 2017

TSTIF

RE:RE:RE:RE:Trump targets pharma

And that's for CTblizzard. Incredibly, that was one of his short posts if...

January 12, 2017

TSTIF

RE:RE:RE:Trump targets pharma

Simple answer.....look at the quality of posts on that board. Could have been...

January 12, 2017

TSTIF

RE:RE:RE:RE:Trump targets pharma

Digital, these types of comments add no value.

January 11, 2017

TSTIF

RE:RE:RE:Trump targets pharma

Give me a f---k--g break.....

January 11, 2017

TSTIF

Liolios

Btw, Liolios has been reasonably useless. From my talks with them, I have not...

January 10, 2017

TSTIF

The Hell with Cheap Takeovers

The handful of "non analysts" in Myrtle held close to 20% of the...

January 10, 2017

TSTIF

RE:RE:RE:4th quarter and 2017 visibility?

He did not say that he would disclose sell through. He tried as best he could...

January 10, 2017

TSTIF

RE:4th quarter and 2017 visibility?

You can keep looking for sell through numbers from the company but you're...

January 10, 2017

TSTIF

RE:Insiders buying

This is Rick's first open market purchase since I can remember. Good for...

January 10, 2017

TSTIF

RE:3 year target. $20

Yes, patients will certainly help. Otherwise you wouldn't need...

January 8, 2017

TSTIF

RE:Re What the---

Tell me the last time you saw coverage launched with a SELL rating? Once in a...

January 8, 2017

TSTIF

RE:Re What the---

I have to disagree. Canaccord has done very little to support the share price...

January 8, 2017

TSTIF

RE:RE:RE:Canaccord Reiterates $5.25 Target!

Not for nothing, but canaccord analyst was carrying 85 unit sales as recently...

January 6, 2017

TSTIF

RE:Canaccord Reiterates $5.25 Target!

The head of Getinge US Capital Spend business worked at J&J for a decade....

January 6, 2017

TSTIF

RE:RE:RE:RE:RE:Investor Day

No discussion of the above and the turnaround time from the FDA was thought...

January 6, 2017

TSTIF

RE:RE:RE:Investor Day

Sitting in the Charlotte airport now......no talk of consumables. And I'd...

January 5, 2017

TSTIF

RE:Investor Day

The company brought in from Portland, OR their lawyer who handles their 510-k...

January 5, 2017

TSTIF

Investor Day

Sitting in the Myrtle Beach airport with a few minutes. The company spent...

January 5, 2017

TSTIF

RE:RE:RE:RE:confused about this receivable factoring

See previous post. In this case I know what I'm talking about.

December 23, 2016

Featured Company